2026 NPPES data Clinical Cardiac Electrophysiology Physician NPI 1225061591 MD
Verify on CMS →

MAHNAZ BEHBOODIKHAH, MD

Clinical Cardiac Electrophysiology Physician in NEWPORT BEACH, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
9K
Medicare Part D claims · 1K beneficiaries · Clinical Cardiac Electrophysiology Physician avg: 2K
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
49.599/100
▼ 34 pts below national avg 83.1 · [object Object]
Industry payments
$1.0K
66 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MAHNAZ BEHBOODIKHAH, MD reported a CMS MIPS final score of 49.599/100 — below the 83.1 national average — and filed 8,803 Medicare Part D claims in 2023.

49.599/100
MIPS score · -34 vs avg
9K
Part D claims, 2023
76%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MAHNAZ BEHBOODIKHAH, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

50 4th percentile higher than 4% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). This entry sits in this band. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MAHNAZ BEHBOODIKHAH, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MAHNAZ BEHBOODIKHAH, MD?

Below national average

NPI registry status

Active

Issued 07/09/2006

NPI 1225061591

Primary specialty

Clinical Cardiac Electrophysiology Physician

Niche

1,570 US NPIs in this specialty

Medicare Part D claims

8,803 452% vs specialty avg

2023 prescription claims

Specialty avg: 1,596

MIPS final score

49.599/100 33.501% pts

Below average band

vs 83.1 national avg

Specialty distribution in California

How Clinical Cardiac Electrophysiology Physician compares to other specialties among California providers

California providers

Clinical Cardiac Electrophysiology Physician share within California

1. Clinical Cardiac Electrophysiology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Clinical Cardiac Electrophysiology Physician share within California

Medicare quality performance — MIPS

MAHNAZ BEHBOODIKHAH, MD's 2023 MIPS final score plotted against the Clinical Cardiac Electrophysiology Physician national average

Below national average
MIPS Final Score
49.599/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Clinical Cardiac Electrophysiology Physician) — 49.599/100 vs national avg 83.1

0%100%National avg83%49.6%
MIPS final score (Clinical Cardiac Electrophysiology Physician) — 49.599/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MAHNAZ BEHBOODIKHAH, MD is a Clinical Cardiac Electrophysiology Physician provider practicing in NEWPORT BEACH, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1225061591. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MAHNAZ BEHBOODIKHAH, MD appears in the CMS NPPES registry as a Clinical Cardiac Electrophysiology Physician provider holding MD credentials at 500 SUPERIOR AVE STE 345, NEWPORT BEACH, CA, 92663, with a listed phone of (949) 646-1877. NPI 1225061591 was issued on 07/09/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BEHBOODIKHAH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 8,803 prescription claims written by this provider, covering 1,051 Medicare beneficiaries and totaling roughly $2.8 million in drug spend, split 24% brand-name and 76% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 49.599/100 for the 2023 performance year (Quality 76.0942, Cost 63.871), compared with the national average of 83.1.

Clinical Cardiac Electrophysiology Physician is a narrow specialty nationwide, with 1,570 enrolled providers across 52 states and an average of 1,596 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

500 SUPERIOR AVE STE 345
NEWPORT BEACH, CA 92663

Provider Details

NPI 1225061591
Specialty Clinical Cardiac Electrophysiology Physician
Credentials MD
Gender Female
NPI Issued 07/09/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

49.599
Final Score
Avg: 83.1
76.0942
Quality
63.871
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MAHNAZ BEHBOODIKHAH, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.0K

Largest payer

Boehringer Ingelheim Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MAHNAZ BEHBOODIKHAH, MD. To verify MAHNAZ BEHBOODIKHAH, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MAHNAZ BEHBOODIKHAH, MD — brand share 24.0%
Specialty average (est.)

24% brand-name claims vs 76% generic, on 8,803 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

8,803
Total Claims
$2.8M
Total Drug Cost
1,051
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
23,292
Total Day Supply
696,434
Brand vs Generic
24% brand / 76% generic
Brand Drug Cost
$2.5M
Generic Drug Cost
$285K
Antibiotic Claims
48

Patient Demographics

Average Patient Age
79.3 years
Avg HCC Risk Score
1.37
Gender Split
57% female / 43% male
Age Distribution
<65: 15, 65-74: 310, 75-84: 429, 85+: 297

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Metoprolol Succinate
982
Eliquis
Apixaban
859
Amlodipine Besylate
569
Rosuvastatin Calcium
529
Xarelto
Rivaroxaban
448
Nebivolol Hcl
396
Diltiazem 24hr Er (Cd)
Diltiazem Hcl
373
Ezetimibe
328
Digoxin
277
Furosemide
269

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Clinical Cardiac Electrophysiology Physician Overview

How MAHNAZ BEHBOODIKHAH, MD fits within the Clinical Cardiac Electrophysiology Physician landscape nationally.

1,570
Clinical Cardiac Electrophysiology Physician Providers in US
52
States with Clinical Cardiac Electrophysiology Physician
1,596
Avg Claims per Provider

MAHNAZ BEHBOODIKHAH, MD's 8,803 claims are above the specialty average of 1,596.

Nearby Clinical Cardiac Electrophysiology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BEHBOODIKHAH.

Compare Clinical Cardiac Electrophysiology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MAHNAZ BEHBOODIKHAH, MD's specialty?
MAHNAZ BEHBOODIKHAH, MD specializes in Clinical Cardiac Electrophysiology Physician and practices in NEWPORT BEACH, California. Credentials: MD.
How much does MAHNAZ BEHBOODIKHAH, MD prescribe under Medicare Part D?
In 2023, MAHNAZ BEHBOODIKHAH, MD wrote 8,803 Medicare Part D claims totaling $2.8M in drug costs for 1,051 beneficiaries.
What is MAHNAZ BEHBOODIKHAH, MD's Medicare quality score?
MAHNAZ BEHBOODIKHAH, MD has a CMS MIPS Final Score of 49.599/100 (Quality: 76.0942, Cost: 63.871). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MAHNAZ BEHBOODIKHAH, MD located?
MAHNAZ BEHBOODIKHAH, MD is located at 500 SUPERIOR AVE STE 345, NEWPORT BEACH, CA, 92663. Phone: (949) 646-1877.
What is MAHNAZ BEHBOODIKHAH, MD's NPI number?
MAHNAZ BEHBOODIKHAH, MD's National Provider Identifier (NPI) is 1225061591, issued on 07/09/2006.
Does MAHNAZ BEHBOODIKHAH, MD prescribe more brand-name or generic drugs?
MAHNAZ BEHBOODIKHAH, MD's prescribing is 24% brand-name and 76% generic drugs by claim count, with $2.5M in brand drug costs.
How many Clinical Cardiac Electrophysiology Physician providers are there in the US?
There are 1,570 Clinical Cardiac Electrophysiology Physician providers across 52 states in the US. The average Clinical Cardiac Electrophysiology Physician provider writes 1,596 Medicare Part D claims per year.
What drugs does MAHNAZ BEHBOODIKHAH, MD prescribe most often?
Based on 2023 Medicare Part D data, MAHNAZ BEHBOODIKHAH, MD's most frequently prescribed drugs include Metoprolol Succinate, Eliquis, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MAHNAZ BEHBOODIKHAH, MD accept Medicare?
MAHNAZ BEHBOODIKHAH, MD appears in CMS Medicare data with 8,803 Part D claims and 1,051 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MAHNAZ BEHBOODIKHAH, MD's credentials?
MAHNAZ BEHBOODIKHAH, MD's NPI is 1225061591 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology